Issues

The cover for this edition of Clinical Science features an illustration of disease states where endothelin targeting treatments have obtained regulatory approval for clinical use or are under clinical investigation, read more in “Is endothelin targeting finally ready for prime time?” by Cardillo and colleagues on pp 635–644.